Taysha Gene Therapies Statistics
Total Valuation
TSHA has a market cap or net worth of $2.04 billion. The enterprise value is $1.83 billion.
| Market Cap | 2.04B |
| Enterprise Value | 1.83B |
Important Dates
The next confirmed earnings date is Tuesday, August 11, 2026, after market close.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TSHA has 319.86 million shares outstanding. The number of shares has increased by 32.50% in one year.
| Current Share Class | 319.86M |
| Shares Outstanding | 319.86M |
| Shares Change (YoY) | +32.50% |
| Shares Change (QoQ) | +2.61% |
| Owned by Insiders (%) | 8.53% |
| Owned by Institutions (%) | 67.58% |
| Float | 226.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 272.72 |
| Forward PS | 730.05 |
| PB Ratio | 8.63 |
| P/TBV Ratio | 9.61 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 244.88 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.04, with a Debt / Equity ratio of 0.32.
| Current Ratio | 14.04 |
| Quick Ratio | 13.76 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2,501.19 |
Financial Efficiency
Return on equity (ROE) is -97.28% and return on invested capital (ROIC) is -41.72%.
| Return on Equity (ROE) | -97.28% |
| Return on Assets (ROA) | -37.77% |
| Return on Invested Capital (ROIC) | -41.72% |
| Return on Capital Employed (ROCE) | -47.30% |
| Weighted Average Cost of Capital (WACC) | 10.43% |
| Revenue Per Employee | $75,465 |
| Profits Per Employee | -$1.31M |
| Employee Count | 99 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +135.85% in the last 52 weeks. The beta is 1.19, so TSHA's price volatility has been higher than the market average.
| Beta (5Y) | 1.19 |
| 52-Week Price Change | +135.85% |
| 50-Day Moving Average | 6.04 |
| 200-Day Moving Average | 5.29 |
| Relative Strength Index (RSI) | 57.18 |
| Average Volume (20 Days) | 2,644,012 |
Short Selling Information
The latest short interest is 45.29 million, so 14.16% of the outstanding shares have been sold short.
| Short Interest | 45.29M |
| Short Previous Month | 41.40M |
| Short % of Shares Out | 14.16% |
| Short % of Float | 20.03% |
| Short Ratio (days to cover) | 10.30 |
Income Statement
In the last 12 months, TSHA had revenue of $7.47 million and -$129.88 million in losses. Loss per share was -$0.38.
| Revenue | 7.47M |
| Gross Profit | 7.47M |
| Operating Income | -132.56M |
| Pretax Income | -129.88M |
| Net Income | -129.88M |
| EBITDA | -131.41M |
| EBIT | -132.56M |
| Loss Per Share | -$0.38 |
Balance Sheet
The company has $276.58 million in cash and $68.55 million in debt, with a net cash position of $208.03 million or $0.65 per share.
| Cash & Cash Equivalents | 276.58M |
| Total Debt | 68.55M |
| Net Cash | 208.03M |
| Net Cash Per Share | $0.65 |
| Equity (Book Value) | 211.94M |
| Book Value Per Share | 0.74 |
| Working Capital | 262.15M |
Cash Flow
In the last 12 months, operating cash flow was -$111.95 million and capital expenditures -$384,000, giving a free cash flow of -$112.33 million.
| Operating Cash Flow | -111.95M |
| Capital Expenditures | -384,000 |
| Depreciation & Amortization | 1.16M |
| Net Borrowing | 9.24M |
| Free Cash Flow | -112.33M |
| FCF Per Share | -$0.35 |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -1,774.37% |
| Pretax Margin | -1,738.40% |
| Profit Margin | n/a |
| EBITDA Margin | -1,758.88% |
| EBIT Margin | -1,774.37% |
| FCF Margin | n/a |
Dividends & Yields
TSHA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -32.50% |
| Shareholder Yield | -32.50% |
| Earnings Yield | -6.37% |
| FCF Yield | -5.51% |
Analyst Forecast
The average price target for TSHA is $13.25, which is 108.01% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $13.25 |
| Price Target Difference | 108.01% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | 149.88% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TSHA has an Altman Z-Score of 2.67 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.67 |
| Piotroski F-Score | 2 |